277 related articles for article (PubMed ID: 32682861)
21. Acceptability and feasibility of self-sampling and follow-up attendance after text message delivery of human papillomavirus results: A cross-sectional study nested in a cohort in rural Tanzania.
Mremi A; Linde DS; Mchome B; Mlay J; Schledermann D; Blaakaer J; Rasch V
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):802-810. PubMed ID: 33555038
[TBL] [Abstract][Full Text] [Related]
22. "The best thing is that you are doing it for yourself" - perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study.
Bakiewicz A; Rasch V; Mwaiselage J; Linde DS
BMC Womens Health; 2020 Mar; 20(1):65. PubMed ID: 32234028
[TBL] [Abstract][Full Text] [Related]
23. Value of conventional pap smear, liquid-based cytology, visual inspection and human papillomavirus testing as optional screening tools among latin american women <35 and > or =35 years of age: experience from the Latin American Screening Study.
Syrjänen K; Derchain S; Roteli-Martins C; Longatto-Filho A; Hammes LS; Sarian L;
Acta Cytol; 2008; 52(6):641-53. PubMed ID: 19068666
[TBL] [Abstract][Full Text] [Related]
24. [A study of cervical cancer screening algorithms].
Zhao FH; Zhang WH; Pan QJ; Zhang X; Chen W; Liu B; Ma JF; Hu SY; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):420-4. PubMed ID: 20819481
[TBL] [Abstract][Full Text] [Related]
25. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries.
Mandelblatt JS; Lawrence WF; Gaffikin L; Limpahayom KK; Lumbiganon P; Warakamin S; King J; Yi B; Ringers P; Blumenthal PD
J Natl Cancer Inst; 2002 Oct; 94(19):1469-83. PubMed ID: 12359856
[TBL] [Abstract][Full Text] [Related]
26. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
[TBL] [Abstract][Full Text] [Related]
27. Determinants of VIA (Visual Inspection of the Cervix After Acetic Acid Application) positivity in cervical cancer screening of women in a peri-urban area in Andhra Pradesh, India.
Vedantham H; Silver MI; Kalpana B; Rekha C; Karuna BP; Vidyadhari K; Mrudula S; Ronnett BM; Vijayaraghavan K; Ramakrishna G; Sowjanya P; Laxmi S; Shah KV; Gravitt PE;
Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1373-80. PubMed ID: 20447927
[TBL] [Abstract][Full Text] [Related]
28. Visual inspection with acetic acid screening for cervical cancer among women receiving anti-retroviral therapy for human immunodeficiency virus infection in northern Tanzania.
Chinn JO; Runge AS; Dinicu AI; Chang J; Maher JA; Crawford EW; Naaseh A; Cooper EC; Zezoff DC; White KM; Lucas AN; Bera KR; Bernstein M; Hari A; Ziogas A; Tewari SE; Pearre DC; Tewari KS
J Obstet Gynaecol Res; 2021 Dec; 47(12):4365-4370. PubMed ID: 34614540
[TBL] [Abstract][Full Text] [Related]
29. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of portable colposcopy and human papillomavirus testing for screening of cervical cancer in rural China.
Newman H; Hu J; Li X; He J; Bradford L; Shan S; Wu X; Zhu B; Yang W; Fu B; Zhu B; Gao G
Int J Gynecol Cancer; 2019 Jan; 29(1):23-27. PubMed ID: 30640679
[TBL] [Abstract][Full Text] [Related]
31. The Influence of Human Papillomavirus Genotypes on Visual Screening and Diagnosis of Cervical Precancer and Cancer.
Jeronimo J; Bansil P; Valdez M; Kang LN; Zhao FH; Qiao YL; Chen W; Zhang X; Paul P; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
J Low Genit Tract Dis; 2015 Jul; 19(3):220-3. PubMed ID: 25279978
[TBL] [Abstract][Full Text] [Related]
32. HPV testing with cytology triage for cervical cancer screening in routine practice.
Louvanto K; Chevarie-Davis M; Ramanakumar AV; Franco EL; Ferenczy A
Am J Obstet Gynecol; 2014 May; 210(5):474.e1-7. PubMed ID: 24373948
[TBL] [Abstract][Full Text] [Related]
33. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
34. Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies.
Fokom-Domgue J; Combescure C; Fokom-Defo V; Tebeu PM; Vassilakos P; Kengne AP; Petignat P
BMJ; 2015 Jul; 351():h3084. PubMed ID: 26142020
[TBL] [Abstract][Full Text] [Related]
35. Cervical cancer awareness and presence of abnormal cytology among HIV-infected women on antiretroviral therapy in rural Andhra Pradesh, India.
Shin SS; Carpenter CL; Ekstrand ML; Wang Q; Grover S; Zetola NM; Yadav K; Sinha S; Nyamathi AM
Int J STD AIDS; 2019 May; 30(6):586-595. PubMed ID: 30813859
[TBL] [Abstract][Full Text] [Related]
36. The Mexican Cervical Cancer Screening Trial: self-sampling for human papillomavirus with unaided visual inspection as a secondary screen.
Belinson JL; Pretorius RG; Enerson C; Garcia F; Cruz EP; Belinson SE; Yeverino García E; Brainard J
Int J Gynecol Cancer; 2009 Jan; 19(1):27-32. PubMed ID: 19258937
[TBL] [Abstract][Full Text] [Related]
37. Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro Region, Tanzania.
Cunningham MS; Skrastins E; Fitzpatrick R; Jindal P; Oneko O; Yeates K; Booth CM; Carpenter J; Aronson KJ
BMJ Open; 2015 Mar; 5(3):e005828. PubMed ID: 25757944
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study.
Shi JF; Canfell K; Lew JB; Zhao FH; Legood R; Ning Y; Simonella L; Ma L; Kang YJ; Zhang YZ; Smith MA; Chen JF; Feng XX; Qiao YL
BMC Cancer; 2011 Jun; 11():239. PubMed ID: 21668946
[TBL] [Abstract][Full Text] [Related]
39. HPV screening for cervical cancer in rural India.
Sankaranarayanan R; Nene BM; Shastri SS; Jayant K; Muwonge R; Budukh AM; Hingmire S; Malvi SG; Thorat R; Kothari A; Chinoy R; Kelkar R; Kane S; Desai S; Keskar VR; Rajeshwarkar R; Panse N; Dinshaw KA
N Engl J Med; 2009 Apr; 360(14):1385-94. PubMed ID: 19339719
[TBL] [Abstract][Full Text] [Related]
40. Screening of cervical neoplasia in HIV-infected women in India.
Joshi S; Sankaranarayanan R; Muwonge R; Kulkarni V; Somanathan T; Divate U
AIDS; 2013 Feb; 27(4):607-15. PubMed ID: 23079814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
